CAMBRIDGE, Mass., Jan. 2, 2007 (PRIME NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced that Steven H. Holtzman, Chief Executive Officer, will be presenting a company overview at the 25th Annual JPMorgan Healthcare Conference. The presentation will take place on Thursday, January 11, 2007 at 8:00 a.m. PST (11:00 a.m. EST) at the Westin St. Francis in San Francisco, Calif.
A webcast of Infinity's presentation will be accessible on the company's website at http://www.ipi.com beginning at 11:00 a.m. PST on Thursday, January 11, 2007. The webcast will be archived on the company's website for 30 days.
About Infinity Pharmaceuticals, Inc.
Infinity is an innovative cancer drug discovery and development company that is seeking to leverage its strength in small molecule drug technologies to discover, develop, and deliver to patients first-in-class or best-in-class medicines for the treatment of cancer and related conditions. For more information on Infinity, please refer to the company's website at http://www.ipi.com.